Refine by
Applications
- Medical cannabis solutions for regulatory pathway sector
- Medical cannabis solutions for mental health costs sector
- Medical solutions for MiniTC and mini-stem system sector
- Colovac - Flexible Endoluminal Bypass Sheath for Patients
- The mat (t) isse bioprothesis: a bio-resorbable tec (tissue engineering chamber)
- Software Solutions for Deep Mutational Scanning & Selection
- Software Solutions for COVID-19
Pre Clinical Study Equipment & Supplies
281 equipment items found
by:OSSIO Inc based inWoburn, MASSACHUSETTS (USA)
Comprised of OSSIOfiber® Intelligent Bone Regeneration Technology, Fully integrates into native anatomy without adverse inflammation,, as proven in pre-clinical studies, Rivals performance of metal headless cannulated compression screws1, Can be trimmed to desired length ...
Manufactured by:Jointechlabs Inc. based inNorth Barrington, ILLINOIS (USA)
Based on our platform and technology, Jointechlabs is developing therapies for unmet medical needs. Our first therapeutic in clinical development JTL-T-01 is a proprietary injectable stem cell scaffold as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program. JTL-T-01 has been designed as an autologous point-of-care therapy enabling the ...
Manufactured by:InVivo BioTech Services GmbH a BRUKER Company based inHennigsdorf, GERMANY
Transient gene expression in mammalian cells provides reasonable amounts of recombinant proteins and antibodies which is sufficient for most applications. Nevertheless, when it comes to bulk productions for in vitro diagnostics or pre-clinical studies for biopharmaceutical development, the required amount of biological material often exceeds the ...
Manufactured by:Wolfmet based inManchester, UNITED KINGDOM
This efficiency, coupled with cost-effectiveness, has made Wolfmet 3D a game-changer in the design and manufacturing of collimators and shielding. Ongoing pre-clinical studies indicate that 3D printed tungsten collimators substantially enhance image quality. Wolfmet 3D's ability to produce standard as well as complex bespoke designs provides ...
by:LIXTE Biotechnology Holdings, Inc. based inPasadena, CALIFORNIA (USA)
Pre-clinical studies showed that LB-100 alone inhibits a spectrum of human cancers but when combined with standard cytotoxic drugs and/or radiation, LB-100 potentiates their effectiveness against hematologic and solid tumor cancers without enhancing toxicity. ...
Manufactured by:AGC Biologics based inBothell, WASHINGTON (USA)
Our ready-to-use platform capabilities are built on cell factories (up to 48L) and bioreactors (up to 200L) using adherent processes, designed entirely in-house. Our quality systems, GMP manufacturing scale and regulatory qualification allow us to meet both clinical and commercial demand. Moreover, our scale down capabilities provide flexible and cost-effective solutions for ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
PLX-Immune are cells that have been induced with tumor necrosis factor alpha (TNF-a) and interferon-gamma (IFN-g), to transiently alter their secretion profile. The product has been evaluated in pre-clinical studies and a peer-reviewed article in the journal Scientific Reports, from Nature, was published which examined the effect of the cells in ...
Manufactured by:Tectonic Therapeutic, Inc. based in
AVROBIO has a preclinical research program for an investigational gene therapy for Gaucher disease type ...
Manufactured by:Tectonic Therapeutic, Inc. based in
AVROBIO has a preclinical research program for a gene therapy for Pompe disease. We have shown a favorable preclinical safety and efficacy profile in a mouse model of Pompe ...
Manufactured by:Anaveon AG based inBasel, SWITZERLAND
The culmination of our research is ANV419, which is in clinical development. It is a rationally engineered fusion protein that is a stable, antibody-like molecule. ...
Manufactured by:CytomX Therapeutics, Inc. based inSouth San Francisco, CALIFORNIA (USA)
CX-188 is our wholly owned PD-1-targeting Probody therapeutic. As with anti-PD-L1 therapies, PD-1 monotherapy and combinations have been associated with significant toxicities. Our preclinical studies have shown that CX-188 has the potential for an improved therapeutic index relative to PD-1 antibodies. The IND for CX-188 was cleared by the FDA. Following a program and portfolio prioritization, ...
Manufactured by:Tectonic Therapeutic, Inc. based in
AVROBIO has a preclinical research program for mucopolysaccharidosis type II (MPS II), or Hunter syndrome. The program is being developed in collaboration with Brian Bigger, Ph.D., who has published favorable preclinical data in a mouse model of Hunter ...
Manufactured by:CTIBiotech based inMeyzieu, FRANCE
Using the latest tools in bioengeneering, our researchers are now printing cancer tissues in 3D. These models can be used for highly significant pre-clinical trials and can be produced in 6/48/96 well plates for high throughput ...
Manufactured by:Elpiscience based inShanghai, CHINA
ES004 is a potentially best-in-class antibody targeting pan-allele signal-regulatory protein alpha (SIRPα). SIRPα is an inhibitory receptor expressed only on myeloid cells and dendritic cells. Binding of CD47 to SIRPα delivers a “don’t eat me” signal to suppress phagocytosis. Tumor cells frequently overexpress CD47 to evade macrophage-mediated destruction. To ...
Manufactured by:EMulate Therapeutics, Inc. based inBellevue, WASHINGTON (USA)
Indolor Therapeutics is feasibility (phase I) trial ready for the treatment of acute and chronic pain by the application of specific pain-managing ulRFE fields, another expression of EMulate’s Therapeutic ...
Manufactured by:Medprin Biotech GmbH based inFrankfurt, GERMANY
100% absorbable within 7-14 days. Hemostasis in capillary, venous as well as small artery bleeding. StypCel™ works when ligation or other conventional methods are impracticable or ...
by:Sorrento Therapeutics, Inc. based inSan Diego, CALIFORNIA (USA)
Sorrento utilizes a proprietary knock-out knock-in (KOKI) technology to modify normal healthy donor derived T cells to genetically engineer them to express the dimeric antigen receptor into T-cell receptor (TCR) alpha chain constant region (TRAC). In this manner, TRAC is knocked out and antigen is knocked into its locus. The Dimeric Antigen Receptor (DAR) utilizes a Fab instead of the scFv ...
Manufactured by:NeuroMD based inNorth Miami Beach, FLORIDA (USA)
The most advanced, FDA-cleared system to restore your lower back health and provide lasting pain relief. Equipped with pre-set, clinically studied NMES parameters, the Corrective Therapy Device® delivers proven electrical stimulation to correct the source of the pain. Get started on the path to relief during our biggest sale ever with savings ...
Manufactured by:BioCydex based inPoitiers, FRANCE
Vectisol® is dedicated to the preservation of organs, tissues and cells. This molecular complex limits the deleterious effects of the ischemia-reperfusion ...
Manufactured by:Elpiscience based inShanghai, CHINA
LAG3 is an immune checkpoint receptor known to suppress T cell activation. We designed ES005 to block LAG3 ligands, including MHC class II and FGL1. Through unique epitope binding, ES005 is able to recognize human LAG3 with high affinity. In preclinical studies, ES005 inhibited tumor growth both as a monotherapy and in combination with a PD-1 ...